Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hakan Kalyon"'
Publikováno v:
Turkish Journal of Hematology, Vol 36, Iss 4, Pp 296-299 (2019)
Externí odkaz:
https://doaj.org/article/49276c2529ad416dad95c1949b9fbb50
Autor:
Elif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, Muhit Ozcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Fergun Yilmaz, Derya Koyun, Nihan Alkis, Inci Alacacioglu, Mehmet Sonmez, Irfan Yavasoglu, Anil Tombak, Ozgur Mehtap, Fatih Kurnaz, Orhan Kemal Yuce, Volkan Karakus, Mehmet Turgut, Derya Deniz Kurekci, Mesut Ayer, Muzaffer Keklik, Deram Buyuktas, Murat Ozbalak, Burhan Ferhanoglu
Glofitamab is a CD3xCD20 bi-specific antibody with two fragments directed to the CD20 antigen and a single CD3-binding fragment. Encouraging response and survival rates were recently reported in a pivotal phase II expansion trial conducted in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2497f4e81be510fd6626ab724fb52159
https://hdl.handle.net/11424/289907
https://hdl.handle.net/11424/289907
Autor:
Burhan Ferhanoglu, Zafer Gulbas, Ant Uzay, Muhit Özcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Asu Fergun Yilmaz, Derya Koyun, Nihan Alkis, Elif Birtas Atesoglu
INTRODUCT ̇ION Glofitamab is a T-cell-engaging bispecific antibody connecting CD20 on B cells and CD3 on T cells. Although, most of the patients with B-cell non-Hodgkin lymphoma (BNHL) achieve complete response (CR) following firstline treatment wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6c58326f2cbd99b6d8617bb5c240e79
https://hdl.handle.net/20.500.12511/10604
https://hdl.handle.net/20.500.12511/10604
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 36, Iss 4, Pp 296-299 (2019)
Turkish Journal of Hematology, Vol 36, Iss 4, Pp 296-299 (2019)
NA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb36416812ab78d1ee2d62b1c8884838
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8605
http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8605
Publikováno v:
The Turkish Journal of Gastroenterology. 25:258-259
Autor:
Hakan Kalyon
Publikováno v:
Yükseköğretim ve Bilim Dergisi, Vol 2, Iss 1, Pp 063-068 (2012)
Universities are the centers where science and knowledge can be produced and shared freely. In these centers, it is probable that disabled people can be in the audience and benefit from these training and education activities. Therefore, removing ine